Medegen Inc. Grows Product Distribution Via Co-Marketing Agreement with C. R. Bard, Inc.

Published: Aug 18, 2008

ONTARIO, Calif.--(BUSINESS WIRE)--Maximus, a business unit of leading infusion therapy firm Medegen Inc., today announced that as a result of a Co-Marketing Agreement between C.R. Bard and Medegen Inc., the MaxPlus® Clear™ needleless access connector will now be included in peripherally inserted central catheter (PICC) kits sold by Bard Access Systems. The agreement provides the extra benefits of the MaxPlus Clear product to users of Bard PowerPICC SOLO*, the newly launched PICC designed to provide the efficiency of power injection for contrast enhanced CT scans and PICC therapy combined with the simplicity of saline care and maintenance through its innovative valve technology.

Back to news